ESMO 2020 Conference Highlights eBOOK
ESMO 2020 Lung Cancer Conference Report In Focus: Lung Cancer Durvalumab Demonstrates...
ESMO Latest
ESMO: Bispecific antibodies targeting PD-1 and CTLA-4: new kids on the block(ade)
Several clinical trials have showed that combining an anti-CTLA-4 inhibitor and an anti-PD-(L)1...